百濟神州(06160.HK):上交所受理公司科創板上市申請
格隆匯1月29日丨百濟神州(06160.HK)公吿,公司已就根據特別授權建議發行人民幣股份及人民幣股份於科創板上市向上交所提交上市申請,但須取決並受限於除其他事項外,市場狀況、股東於公司股東特別大會上的批准及監管批准。於2021年1月29日,上交所通知公司其已受理該上市申請。
將予發行的人民幣股份數目(包括超額配股權)不會超過1.32億股股份,即不超過公司於2021年1月7日已發行股份總數及建議發行人民幣股份項下擬發行及配發的人民幣股份數目之和的10%。
經扣除發行開支後,建議發行人民幣股份的所得款項淨額擬用於臨牀研發項目(66%);研發中心建設(2%);生物藥生產基地建設(1%);營銷網絡擴張(1%);及補充營運資金(30%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.